- Home
- SBS vs HOLX Comparison
SBS vs HOLX Comparison
Compare SBS & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SBS | HOLX |
|---|---|---|
| Founded | 1954 | 1985 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Water Supply | Medical Electronics |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.4B | 16.6B |
| IPO Year | 2002 | 1990 |
Fundamental Metrics
Financial Performance| Metric | SBS | HOLX |
|---|---|---|
| Price | $25.04 | $74.91 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 15 |
| Target Price | N/A | ★ $79.64 |
| AVG Volume (30 Days) | 1.2M | ★ 3.0M |
| Earning Date | 11-10-2025 | 11-03-2025 |
| Dividend Yield | ★ 2.18% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 1.98 | ★ 2.49 |
| Revenue | ★ $6,502,517,346.00 | $4,100,500,000.00 |
| Revenue This Year | N/A | $6.69 |
| Revenue Next Year | $14.38 | $5.74 |
| P/E Ratio | ★ $12.82 | $30.11 |
| Revenue Growth | N/A | ★ 1.74 |
| 52 Week Low | $13.87 | $51.90 |
| 52 Week High | $27.25 | $80.31 |
Technical Indicators
Market Signals| Indicator | SBS | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 44.39 | 67.93 |
| Support Level | $26.53 | $74.55 |
| Resistance Level | $27.08 | $75.12 |
| Average True Range (ATR) | 0.60 | 0.28 |
| MACD | -0.09 | -0.14 |
| Stochastic Oscillator | 4.96 | 78.92 |
Price Performance
Historical ComparisonAbout SBS Companhia de saneamento Basico
Companhia De Saneamento Basico Do Estado De Sao Paulo is engaged in the provision of basic and environmental sanitation services in the Sao Paulo State and supplies treated water and sewage services on a wholesale basis. The company operates in a single segment, which is Sanitation services.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.